NCT00783952

Brief Summary

The purpose of this study is to test a new way to measure the oxygen level in the mixed venous blood system (the system that carries blood collected from all over the body to the heart), which is a very important monitoring tool for the overall oxygen delivery to all our tissues. This new way measures the oxygen level in the mixed venous blood from outside the body, instead of measuring from the inside through a catheter (a thin, flexible plastic tube) that is placed by breaking the skin.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2008

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 30, 2008

Completed
2 days until next milestone

Study Start

First participant enrolled

November 1, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 3, 2008

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2013

Completed
4.3 years until next milestone

Results Posted

Study results publicly available

April 20, 2017

Completed
Last Updated

April 20, 2017

Status Verified

March 1, 2017

Enrollment Period

4.2 years

First QC Date

October 30, 2008

Results QC Date

October 28, 2016

Last Update Submit

March 8, 2017

Conditions

Keywords

Mixed venous oxygen saturationTissue oxygenationNear infrared spectroscopy

Outcome Measures

Primary Outcomes (1)

  • Determining the Accuracy of Mixed Venous Oxygen Saturation Obtained With a Novel Mathematical Equation Using Arterial Oxygen Saturations and Various Local Tissue Oxygen Saturations.

    Four sensors of the 'Cerebral/Somatic Tissue Oximeter' device will be placed on subject's both sides of the forehead, palm and calf area. Simultaneously, blood samples will be drawn from the pulmonary artery catheter and arterial line for blood gas analyses. The values obtained from the device measurements will be used in a new equation to calculate the mixed venous oxygen saturation. The calculated value will be compared to the real value from the blood gas analysis for accuracy.

    6 months

Study Arms (1)

1

OTHER

Mixed venous oxygen saturation measurement obtained from blood drawn from a pulmonary artery catheter.Calculation of mixed venous oxygen saturation from the measurement of peripheral oxygen saturations using multiple Cerebral/Somatic Tissue Oximeter device probes

Device: Cerebral/Somatic Tissue Oximeter deviceDevice: Pulmonary artery catheter

Interventions

Measurement of tissue oxygen saturation and simultaneous sampling for blood gas analysis. Four sensors of the 'Cerebral/Somatic Tissue Oximeter' device will be placed on subject's both sides of the forehead, palm and calf area. Simultaneously, blood samples will be drawn from the pulmonary artery catheter and arterial line for blood gas analyses. The values obtained from the device measurements will be used in a new equation to calculate the mixed venous oxygen saturation. The calculated value will be compared to the real value from the blood gas analysis for accuracy.

1

Blood will be drawn form the pulmonary artery catheter for measurement of mixed venous oxygen saturation.

1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients already being monitored by a pulmonary artery catheter and an arterial line

You may not qualify if:

  • Patients with severe heart failure
  • Patients with carbon monoxide or thiocyanate poisoning

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

Results Point of Contact

Title
Robert M Kacmarek PhD, RRT
Organization
Massachusetts General Hospital

Study Officials

  • Robert Kacmarek, PhD, RRT

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Anesthesia, Director of Respiratory Care Services

Study Record Dates

First Submitted

October 30, 2008

First Posted

November 3, 2008

Study Start

November 1, 2008

Primary Completion

January 1, 2013

Study Completion

January 1, 2013

Last Updated

April 20, 2017

Results First Posted

April 20, 2017

Record last verified: 2017-03

Locations